Abstract
Purpose: Surgical site infection (SSI) is a debilitating complication of total joint arthroplasty (TJA) with significant morbidity and increased costs. Aim of our study was to identify potential risk factors for SSIs in a population of patients undergoing TJA. Methods: TJA were prospectively recruited at Santa Maria Maddalena Hospital from February 2019 to April 2020. Age, sex, major comorbidities, American Society of Anesthesiologists (ASA) class, length of surgery, type of surgical suture, total hospital length of stay and clinical laboratory data were collected. The study population was then divided into two groups: Group A, normal post-operative course, and Group B, patients who developed SSI at follow-up (17-25 days).Results: 25/760 (3.3%) patients developed SSIs at follow-up. Clinical and demographic parameters were not different between the two groups. Total leucocyte and neutrophil values at discharge resulted to be significatively higher in Group B compared to Group A (p=0.025 and p=0.016, respectively). Values of 7860/mL for total leucocyte, and 5185/mL for neutrophil count at discharge significantly predicted the future development of SSI (AUC 0.623 and AUC 0.641, respectively; p<0.05) independently from confounding factors (total leukocytes: O.R.=3,69 [95% C.I. 1,63-8,32]; neutrophils: O.R.=3,98 [95% C.I. 1,76-8,97. Deep SSIs has been diagnosed significantly before superficial SSIs (p=0,008), with a median advance of 9 days. Conclusion: Total leukocytes and neutrophils at discharge seem useful to identify a population at risk for the development of SSIs following TJA. Further studies on larger populations are needed to develop a predictive SSIs risk score that should include those variables.